Attached files

file filename
8-K - 8-K - SRS LABS INCa11-23595_18k.htm

Exhibit 99.1

 

GRAPHIC

 

FOR IMMEDIATE RELEASE

 

SRS Labs Reports Second Quarter 2011 Results

 

Santa Ana, Calif., August 4, 2011 - SRS Labs, Inc. (NASDAQ: SRSL), officially recognized as one of America’s Greatest Brands and the industry leader in surround sound, audio and voice technologies reported financial results for the second quarter ended June 30, 2011.

 

Revenues in the second quarter 2011 increased 6% to $7.6 million from $7.2 million in the same period a year ago. The increase was attributable to higher licensing revenues in the personal telecommunications market, offset by decreased revenues in the automotive and home entertainment markets. The revenue growth was also attributable to increased product sales during the quarter.

 

Operating expenses in the second quarter 2011 increased 23% to $8.0 million from $6.5 million in the same year-ago period. The increase is partially due to the company’s investments in resources in anticipation of growth in emerging market segments. These investments have contributed to our efforts to explore new business opportunities. The company believes it is appropriately staffed to meet its current objectives, while remaining positioned for strategic expansion in order to address new opportunities as they arise.

 

Net loss in the second quarter 2011 was $538,000 or $(0.04) per diluted share compared to a net income of $631,000 or $0.04 per diluted share in the second quarter of 2010.

 

Quarter-end cash and cash equivalents, and short-term and long-term investments remained consistent at $42.3 million as of June 30, 2011 and March 31, 2011.

 

Management Commentary

 

“While up year-over-year, our second quarter results were affected by the many difficulties our OEM partners faced in the prior quarter,” said Thomas C.K. Yuen, SRS Lab’s chairman and CEO. “After beginning the year with a larger than expected channel inventory, our TV customers reduced production and delayed new product model launches.  In the PC segment, Intel’s recall and delayed shipment of its Sandy Bridge chipset adversely affected manufacturing and sales of new notebook models and, despite analyst expectations, the notebook market also experienced slower than expected sales partially due to the launch of multiple media tablets. Similarly, our automotive segment was impacted by the disastrous earthquake and subsequent tsunami which halted auto production in Japan. On a more positive note, our mobile segment revenue grew respectably in Q2, more than offsetting the weaker revenue contributions from the TV, PC and auto segments.”

 

“Our second half expectations remain high as we anticipate further progress in the mobile segment  benefited in part by our partnership with Qualcomm and burgeoning media tablets. In addition, with the dissipation of the industry’s overstocked flat panel inventory and our recent design wins with new and existing TV OEMs, we expect positive changes in revenues generated from our TV segment. Lastly, with the PC segment regaining impetus, we expect to continue penetrating deeper within our current accounts and gain new design wins.”

 

“Our revenue expectations for the balance of the year remain principally unchanged. Given our new design wins, business opportunities in progress and contracts signed, we continue to target 25% revenue growth in 2011 and plan on delivering profit margins that commensurate with our business model, although we are wary of the state of the global economy and remain watchful of its lingering weakness.”

 

“We announced in February 2011 a stock repurchase program whereby the company may acquire up to one million shares of its outstanding stock through December 2011.  We intend to continue to repurchase the company’s stock as we believe it communicates our confidence in the strength of our

 



 

business, growth opportunities, and our long-term strategy, as well as demonstrates our commitment to building shareholder value.”

 

Conference Call

 

SRS Labs will hold a conference call later today (August 4, 2011) to discuss these second quarter 2011 financial results. Chairman and CEO Thomas C.K. Yuen will host the call starting at 5:00 p.m. Eastern time. A question and answer session will follow management’s presentation.

 

Dial-In Number: 1-877-353-2262
Conference ID#: 80547441

 

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization and instruct you to wait until the call begins. If you have any difficulty connecting with the conference call, please contact Liolios Group at 949-574-3860. Investors may also listen to the conference call live online via a link available on the SRS Labs investor relations home page at www.srslabs.com. The website will host a replay of the call available after 8:00 p.m. Eastern time. Investors may also listen to the replay by dialing 800-642-1687 and entering conference ID#: 80547441, available until August 18, 2011.

 

About SRS Labs, Inc.

 

Founded in 1993, SRS Labs is the industry leader in audio signal processing for consumer electronics across the four screens: TV; PC; Mobile Phones; and Automotive Entertainment Systems. Beginning with the audio technologies originally developed at Hughes Aircraft, SRS Labs holds over 150 worldwide patents and is recognized by the industry as the foremost authority in research and application of audio post processing technologies based on the human auditory principles. Through partnerships with leading global CE companies, semiconductor manufacturers, software developers, and content aggregators, SRS is recognized as the de facto standard in audio enhancement, surround sound, volume leveling, audio streaming, and voice processing technologies. SRS solutions have been included in over two billion electronic products sold worldwide including flat panel HDTVs, AV products, STBs, PCs, mobile phones, and automotive entertainment and telematics systems. For more information, visit www.srslabs.com.

 

Safe Harbor Statement

 

This press release includes forward-looking statements that are based on our current expectations, estimates and projections about SRS Labs, Inc., management’s beliefs and certain assumptions made by us, and events beyond our control, all of which are subject to change. Such forward-looking statements include, but are not limited to, statements relating to the market demand for our solutions, our future growth opportunities, competitive position, expansion and investment plans, as well as our future operating results and profitability. Forward-looking statements can often be identified by words such as “expects,” “anticipates,” “intends,” “plans,” “predicts,” “believes,” “seeks,” “estimates,” “may,” “will,” “should,” “would,” “could,” “likely,” “potential,” “continue,” similar expressions, and variations or negatives of these words. These forward-looking statements are not guarantees of future results or the commitments made by us herein, and they are subject to risks, uncertainties and assumptions that could cause actual results to differ materially and adversely from those expressed in any forward-looking statement. The risks and uncertainties referred to above include, but are not limited to, the loss of any significant customer; the acceptance of new SRS Labs products and technologies; our ability to increase our brand awareness and enter into new or expanded license arrangements; the impact of competitive products and pricing; general economic and business conditions that may adversely impact sales of consumer products incorporating our technologies or that otherwise may impact our operating results and future performance; the timely development and release of technologies by the Company; and such other factors described in our filings with the Securities and Exchange Commission. The forward-looking statements in this press release speak only as of the date they are made. We do not undertake any obligation to revise or update publicly any forward-looking statement for any reason.

 

Investor Relations Contact:

Matt Glover
Investor Relations
Liolios Group, Inc.
Tel 949-574-3860
info@liolios.com

 



 

SRS LABS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

 

June 30,
2011

 

December 31,
2010

 

 

 

(Unaudited)

 

 

 

ASSETS

 

 

 

 

 

Current Assets

 

 

 

 

 

Cash and cash equivalents

 

$

9,847,492

 

$

10,697,827

 

Accounts receivable, net

 

1,352,963

 

1,191,847

 

Prepaid expenses and other current assets

 

1,546,511

 

1,069,900

 

Short-term investments

 

25,937,000

 

19,033,000

 

Total Current Assets

 

38,683,966

 

31,992,574

 

 

 

 

 

 

 

Long-term investments

 

6,524,000

 

13,323,000

 

Property and equipment, net

 

1,294,686

 

672,220

 

Intangible assets, net

 

2,600,358

 

2,761,432

 

Deferred income taxes, net

 

10,170,288

 

8,597,619

 

Total Assets

 

$

59,273,298

 

$

57,346,845

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

Accounts payable

 

$

976,785

 

$

516,470

 

Accrued liabilities

 

1,675,940

 

1,434,970

 

Deferred revenue

 

634,549

 

601,825

 

Total Current Liabilities

 

3,287,274

 

2,553,265

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ Equity

 

 

 

 

 

Preferred stock—$0.001 par value; 2,000,000 shares authorized; no shares issued and outstanding

 

 

 

Common stock—$0.001 par value; 56,000,000 shares authorized; 14,914,998 issued and 14,885,667 outstanding at June 30, 2011 and 14,807,070 shares issued and outstanding at December 31, 2010

 

14,916

 

14,808

 

Additional paid-in capital

 

70,218,809

 

68,520,878

 

Treasury stock at cost, 29,331 and 0 shares at June 30, 2011 and December 31, 2010, respectively

 

(259,805

)

 

Accumulated deficit

 

(13,987,896

)

(13,742,106

)

Total Stockholders’ Equity

 

55,986,024

 

54,793,580

 

Total Liabilities and Stockholders’ Equity

 

$

59,273,298

 

$

57,346,845

 

 



 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30,

 

June 30,

 

 

 

2011

 

2010

 

2011

 

2010

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

7,602,066

 

$

7,161,030

 

$

15,783,259

 

$

15,546,422

 

Cost of sales

 

191,923

 

99,870

 

339,054

 

164,355

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

7,410,143

 

7,061,160

 

15,444,205

 

15,382,067

 

 

 

 

 

 

 

 

 

 

 

Operating expenses (i):

 

 

 

 

 

 

 

 

 

Sales and marketing

 

3,986,544

 

3,221,144

 

7,788,261

 

6,641,687

 

Research and development

 

2,168,692

 

1,826,118

 

4,482,366

 

3,716,112

 

General and administrative

 

1,843,754

 

1,431,833

 

3,511,941

 

2,997,131

 

Total operating expenses

 

7,998,990

 

6,479,095

 

15,782,568

 

13,354,930

 

 

 

 

 

 

 

 

 

 

 

Operating (loss) income

 

(588,847

)

582,065

 

(338,363

)

2,027,137

 

Other income, net

 

50,690

 

71,863

 

95,357

 

101,502

 

(Loss) income before income taxes

 

(538,157

)

653,928

 

(243,006

)

2,128,639

 

Income taxes

 

 

23,095

 

2,784

 

31,463

 

Net (loss) income

 

(538,157

)

$

630,832

 

(245,790

)

$

2,097,176

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.04

)

$

0.04

 

$

(0.02

)

$

0.14

 

Diluted

 

$

(0.04

)

$

0.04

 

$

(0.02

)

$

0.14

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares used in the per share calculations:

 

 

 

 

 

 

 

 

 

Basic

 

14,879,292

 

14,637,238

 

14,872,801

 

14,604,933

 

Diluted

 

14,879,292

 

15,642,573

 

14,872,801

 

15,479,199

 

 


(i)  Includes share-based compensation expense as follows:

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30,

 

June 30,

 

 

 

2011

 

2010

 

2011

 

2010

 

 

 

 

 

 

 

 

 

 

 

Sales and marketing

 

231,248

 

168,594

 

450,997

 

345,789

 

Research and development

 

143,974

 

135,238

 

292,780

 

284,746

 

General and administrative

 

234,175

 

241,927

 

493,839

 

496,386

 

Total share-based compensation expense

 

609,397

 

545,759

 

1,237,616

 

1,126,921